Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Ranibizumab in Polypoidal Choroidal Vasculopathy
NCT01248117Phase 2Unknown
- Sponsor
- Retina Consultants of Hawaii
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in polypoidal choroidal vasculopathy (PCV), sponsored by Retina Consultants of Hawaii. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT01248117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248117.